DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

MannKind Corp (NASDAQ: MNKD)

6.18 0.03 (0.49%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $6.18 0.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.20
Previous Close $6.15
Daily Range $6.06 - $6.32
52-Week Range $3.80 - $11.48
Market Cap $2.5B
P/E Ratio -10.60
Dividend (Yield) $0.00 (0.0%)
Volume 4,358,630
Average Daily Volume 5,533,469
Current FY EPS -$0.46

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

Is this MannKind Corporation's Worst Nightmare?

MannKind's long-awaited inhaled insulin product is nearing a commercial launch. The drug may be in for a bumpier ride than most expect, however. Here's why.

US IPO Weekly Recap: Burgers and bionic eyes gain over 100% as 9 companies go public

Sanofi's New Medicines Seminar: Implications For Afrezza

Biotech Stock Mailbag: Northwest Bio, Celldex, Puma, MannKind

Second Sight sees double: Year's 6th IPO to soar 100% on day one

Sanofi: Recent Plunge Is A Buying Opportunity

Benzinga's Top #PreMarket Gainers

Biotech Stock Mailbag: Spectrum, Intercept, Orexigen, Amarin, MannKind

MannKind's (MNKD) CEO Alfred Mann on Q3 2014 Results - Earnings Call Transcript

MannKind Is On The Mend

See More MNKD News...

MNKD's Top Competitors

MNKD $6.18 (0.49%)
Current stock: MNKD
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
BIIB $303.55 (1.49%)
Current stock: BIIB